Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline

123
8
Favorite

Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline

seekingalpha2021-12-31

GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

123

Report

Comment（8）

beebeeyan
·2021-12-31
張學友
Reply
1
Report
RobinChanKH
·2021-12-31
Gogo
Reply
2
Report
FatKid
·2021-12-31
K
Reply
2
Report
geraldwwx
·2021-12-31
🤡
Reply
2
Report
k1wong
·2021-12-31
K
Reply
2
Report
Tj23
·2021-12-31
Wow
Reply
2
Report
Vicholes
·2021-12-31
[smile]
Reply
3
Report
Doris11
·2021-12-31
Like please
Reply
5
Report
Fold Replies
- Jyozu:
  Pls like ba ck
  2021-12-31
  Reply
  Report
- beebeeyan:
  下
  2021-12-31
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1177858565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-31 09:26","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1177858565","market":"us","top_or_hot":-1,"title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","media":"seekingalpha","content":"<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","article_id":"1177858565","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","pubTimestamp":1640913974,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"GLJ Research公司的Tilray认为股价下跌88%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":0.9},"content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":692865269,"gmtCreate":1640917673676,"gmtModify":1676532505020,"author":{"id":"3581331692871918","authorId":"3581331692871918","name":"beebeeyan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581331692871918","authorIdStr":"3581331692871918"},"htmlText":"張學友","listText":"張學友","text":"張學友","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/692865269","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9003147912,"gmtCreate":1640915672057,"gmtModify":1676533554587,"author":{"id":"3585125163446793","authorId":"3585125163446793","name":"RobinChanKH","avatar":"https://community-static.tradeup.com/news/6a29bc2ef443d458e3076e29dd8d5455","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":4,"crmLevelSwitch":1,"idStr":"3585125163446793","authorIdStr":"3585125163446793"},"htmlText":"Gogo","listText":"Gogo","text":"Gogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003147912","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9003147059,"gmtCreate":1640915657724,"gmtModify":1676533554615,"author":{"id":"4090418903913760","authorId":"4090418903913760","name":"FatKid","avatar":"https://community-static.tradeup.com/news/f6692ab34697d0d2f7947fa3f34c6421","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4090418903913760","authorIdStr":"4090418903913760"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003147059","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9003144099,"gmtCreate":1640915474257,"gmtModify":1676533554569,"author":{"id":"3555322280934257","authorId":"3555322280934257","name":"geraldwwx","avatar":"https://static.tigerbbs.com/bccdb31724278699a26408ea1426d1d2","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3555322280934257","authorIdStr":"3555322280934257"},"htmlText":"🤡","listText":"🤡","text":"🤡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003144099","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9003145583,"gmtCreate":1640915453664,"gmtModify":1676533554561,"author":{"id":"3574996050082067","authorId":"3574996050082067","name":"k1wong","avatar":"https://community-static.tradeup.com/news/677b37ef7f68f9ac2e51ca5f6ad6ef5e","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":1,"idStr":"3574996050082067","authorIdStr":"3574996050082067"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003145583","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9003142506,"gmtCreate":1640915236813,"gmtModify":1676533554540,"author":{"id":"3571780042589602","authorId":"3571780042589602","name":"Tj23","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571780042589602","authorIdStr":"3571780042589602"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003142506","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9003146649,"gmtCreate":1640915133943,"gmtModify":1676533554514,"author":{"id":"4088125554959510","authorId":"4088125554959510","name":"Vicholes","avatar":"https://static.itradeup.com/news/a52c68e0b84d7f61c9d9ccf225bb2bb8","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088125554959510","authorIdStr":"4088125554959510"},"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003146649","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":692889262,"gmtCreate":1640914514420,"gmtModify":1676532504553,"author":{"id":"3583011761877766","authorId":"3583011761877766","name":"Doris11","avatar":"https://static.tigerbbs.com/3358aeedff213df7d1787b8f5e7a99ec","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583011761877766","authorIdStr":"3583011761877766"},"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/692889262","repostId":1177858565,"repostType":4,"repost":{"id":"1177858565","kind":"news","pubTimestamp":1640913974,"share":"https://ttm.financial/m/news/1177858565?lang=&edition=fundamental","pubTime":"2021-12-31 09:26","market":"us","language":"en","title":"Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177858565","media":"seekingalpha","summary":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.Th","content":"<html><head></head><body><p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.</p><p>The firm has an $0.82 price target (~88% downside based on yesterday&#39;s close).</p><p>Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn&#39;t increased revenue in years even though there has been tremendous growth in the global cannabis market.</p><p>He adds that the company&#39;s revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray a Sell at GLJ Research as Firm Sees 88% Stock Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray a Sell at GLJ Research as Firm Sees 88% Stock Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://seekingalpha.com/news/3784140-tilray-a-sell-at-glj-research-as-firm-sees-88-stock-decline","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177858565","content_text":"GLJ research views Tilray(NASDAQ:TLRY)as a sell and foresees a drastic decline in its share price.The firm has an $0.82 price target (~88% downside based on yesterday's close).Analyst Gordon Johnson II says that the combined Tilray/Aphria hasn't increased revenue in years even though there has been tremendous growth in the global cannabis market.He adds that the company's revenue would need to grow materially to justify its current valuation. Otherwise, growth will continue to stagnate, leading to further share decline.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100069008,"gmtCreate":1640915936538,"gmtModify":1663241735762,"authorId":3585370461477110,"author":{"id":3585370461477110,"idStr":"3585370461477110","authorId":3585370461477110,"name":"Jyozu","avatar":"https://static.tigerbbs.com/ac83cb007e9144d9710ce08e1d562f3b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":692889262,"type":1,"supId":0,"prevId":0,"content":"Pls like ba ck","text":"Pls like ba ck","html":"Pls like ba ck"},{"id":7143455,"gmtCreate":1640917680528,"gmtModify":1663239341436,"authorId":3581331692871918,"author":{"id":3581331692871918,"idStr":"3581331692871918","authorId":3581331692871918,"name":"beebeeyan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":692889262,"type":1,"supId":0,"prevId":0,"content":"下","text":"下","html":"下"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":123,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}